Cybin Inc. reported raising $317,000 in an initial SEC Form D filing, from an offering of $317,000
Amount Raised
$317,000
Round Type
Venture
TorontoOtherManufacturingBiotechnologyHealth CarePharmaceuticalWho else raised in Pharmaceutical and Manufacturing around the same time
Companies in the same sectors as Helus Pharma that raised within 45 days of this round, from Fundz verified event records.
- Treace raised $150M (Debt Financing) on May 2, 2022.
- SciTech Development raised an undisclosed amount on April 26, 2022.
- ENDRA Life Sciences raised $8.7M (Post-IPO Equity) on April 21, 2022.
- Candesant Biomedical, Inc. raised $35M on April 12, 2022.
- Danaher raised an undisclosed amount (Series A) on April 12, 2022.
- Neochord raised $1.8M (Seed) on March 8, 2022.
Who to call at Helus Pharma, and when
A new round usually means Helus Pharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Helus Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Helus Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Helus Pharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Helus Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Helus Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.